CD15, humanCatalog number: CD15-1
The antibody against CD15 CD15 is a helpful tool for the identification of Reed-Sternberg-Cells in Hodgkin's disease. Occasionally CD15 is exprimed also in large cell B- and T-cell lymphoma. CD15 or X-Hapten plays a role in mediating phagocytosis, bacterial activity and chemotaxis. It is present on >95% of granulocytes including neutrophils and eosinophils and to a lesser degree monocytes. It is also present on Reed-Sternberg cells and on some epithelia. Human CD15 (3-fucosyl-N-acetyllactosamine).
Immunogen: U937 histiocytic cell line
Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide**. The volume is sufficient for at least 100 immunohistochemical tests (100 µl working solution / test). Use appropriate antibody diluent e.g. BIOLOGO Art .No. PU002.
Purification Method: Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide**. The volume is sufficient for at least 100 immunohistochemical tests (100 µl working solution / test). Use appropriate antibody diluent e.g. BIOLOGO Art .No. PU002.
Secondary Reagents: As secondary reagents we recommend the use of biotinylated anti-mouse IgM antibody (Art. No. BA-2020) in combination with streptavidin conjugates or ABC systems.
Concentration: 50 µg/ml
Species Reactivity: Human
Incubation Time: 60 min at RT
Working Concentration: (liquid conc.) 1:15-1:25
Pre-Treatment: Formaldehyde-fixed material should be treated with Unmasking Solution C, citrate buffered solution pH 6 (Art. No. DE000) at 96-100°C followed by short term treatment with Pepsin (0.1%)
Positive Control: Reed-Sternberg cells in Hodgkin's disease
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Exalpha Biologicals accepts no liability for any inaccuracies or omissions in this information.
1. Skubitz K. et al. In: White Cell Differentiation Antigens. New York / Oxford University Press 1989; 800-805.
Safety Datasheet(s) for this product: